Biota Holdings Limited (ASX:BTA) Announced Thier Relenza Royalty for March 2009 Quarter At A$32.3 Million

Biota Holdings Limited (ASX:BTA)(PINK:BTAHY) today announced that it had received notification from GlaxoSmithKline (LON:GSK) that Relenza sales were A$462 million and indicative royalties were A$32.3 million, for the three months ended 31 March 2009.

Indicative royalties for the nine months to 31 March 2009 total A$36.1 million.

Biota CEO Peter Cook attributed the performance to recent significant orders for pandemic stockpiling from the UK and Japanese Governments.

About Biota Holdings Limited

 

Related Companies

GlaxoSmithKline plc
      

Biota Holdings Limited